ECM1 Expression in Thyroid Tumors-A Comparison of Real-Time RT-PCR and IHC

Journal of Surgical Research

Volumn 149, Issue 1, 2008, Pages 62-68

  Lal, Geeta ^a   Padmanabha, Lakshmi ^a   Nicholson, Rachael ^a   Smith, Brian J ^a   Zhang, Lurong ^a   Howe, James R ^a   Robinson, Robert A ^a   O'Dorisio, M Sue ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

diagnosis; ECM1; immunohistochemistry; molecular markers; real time RT PCR; thyroid cancer

Indexed keywords

ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; EXTRACELLULAR MATRIX 1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROC CURVE; THYROID TUMOR;

EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 48949083095     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.10.014     Document Type: Article

References (19)

1. Ries LAG, Melbert D, Krapcho M, et al. (Eds). SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute, based on November 2006 SEER data submission, posted to the SEER website, 2007. Available at: http://www.seer.cancer.gov/csr/1975_2004.
2. Bhalerao J., Tylzanowski P., Filie J.D., et al. Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse. Demonstration of alternative splicing in skin and cartilage. J Biol Chem 270 (1995) 16385
3. Han Z., Ni J., Smits P., et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J 15 (2001) 988
4. Wang L., Yu J., Ni J., et al. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 200 (2003) 57
5. Pauws E., Veenboer G.J., Smit J.W., et al. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles. FASEB J 18 (2004) 560
6. Kebebew E., Peng M., Reiff E., et al. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 242 (2005) 353
7. Takano T., Miyauchi A., Yokozawa T., et al. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59 (1999) 4542
8. Relative quantitation of gene expression. ABI's User Bulletin No. 2. Applied Biosystems (1997)
9. Kurtz K.A., Hoffman H.T., Zimmerman M.B., et al. Perineural and vascular invasion in oral cavity squamous carcinoma: Increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch Pathol Lab Med 129 (2005) 354
10. Ginzinger D.G. Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp Hematol 30 (2002) 503
11. Mocellin S., Rossi C.R., Pilati P., et al. Quantitative real-time PCR: A powerful ally in cancer research. Trends Mol Med 9 (2003) 189
12. Nuciforo P.G., Pellegrini C., Fasani R., et al. Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma. Hum Pathol 34 (2003) 639
13. Xing M., Tokumaru Y., Wu G., et al. Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res 63 (2003) 2312
14. Bartolazzi A., Gasbarri A., Papotti M., et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357 (2001) 1644
15. Mills L.J., Poller D.N., and Yiangou C. Galectin-3 is not useful in thyroid FNA. Cytopathology 16 (2005) 132
16. Dwight T., Thoppe S.R., Foukakis T., et al. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 88 (2003) 4440
17. Kroll T.G., Sarraf P., Pecciarini L., et al. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289 (2000) 1357 Erratum in Science 2000;289:1474
18. Marques A.R., Espadinha C., Catarino A.L., et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87 (2002) 3947
19. Tsuda H. HER-2 (c-erbB-2) test update: Present status and problems. Breast Cancer 13 (2006) 236